Principal Software Developer - SafeTrace Tx
Haemonetics Corporation4 months ago
Boston, MA, USAStaff+
Base Salary
$104k - $176k/yr
Responsibilities
- Define the long-term technical roadmap, engineering standards, architecture, and core technology adoption.
- Serve as the final authority on critical design decisions, quality gates, and performance budgets.
- Prototype foundational systems, conduct high-level code reviews, and resolve high-risk architectural challenges.
- Mentor engineering team members and promote technical rigor and continuous improvement.
- Identify and mitigate technical debt, performance bottlenecks, and architectural risks.
- Design scalable integrations and multi-facility data exchange for hospital information systems and transfusion workflows.
- Align technical architecture with regulatory and commercial objectives.
Requirements
- 10+ years of software engineering experience.
- 5+ years of experience in a Principal or Architect role.
- Expertise in C# or other object-oriented languages such as Java or Python.
- Experience with RESTful APIs, service-oriented and event-driven architecture, high availability, containerization, SQL, NoSQL, and related architectural practices.
- Experience with AWS services including ECS, EKS, RDS, Lambda, S3, SQS, and CloudFormation, as well as Terraform.
- Experience with OWASP best practices, OIDC, SAML2, SOC2, ISO27001, and HIPAA compliance.
- A proven record of shipping multiple complex products with stable, maintainable architectures.
- Ability to communicate complex technical concepts to engineers and executive leadership.
- Ability to balance immediate production needs with long-term architectural health.
Benefits
- Benefits include a 401(k) with up to a 6% employer match and no vesting period, employee stock purchase plan, flexible time off or accrued vacation, paid sick time, paid and floating holidays, parental leave, short- and long-term disability insurance, tuition reimbursement, health and welfare benefits, discretionary annual bonus eligibility, and potential long-term incentive plan participation.
About Haemonetics Corporation
Haemonetics Corporation builds medical devices, disposables, and software for blood and plasma collection, transfusion management, surgery, and interventional procedures. Its portfolio includes apheresis platforms for plasma centers, surgical blood salvage systems, blood management software, and vascular closure and sensor-guided technologies sold to hospitals, blood banks, and collection networks. Founded in 1971 and headquartered in Boston, it is a publicly traded company on the NYSE.